Back
Cogent Biosciences, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
46
COGT
Cogent Biosciences, Inc.
Last Price:
$35.37
Seasonality Move:
-19.09%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atCogent Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Cogent Biosciences, Inc. has on average historically risen by 77.9% based on the past 7 years of stock performance.
-
Cogent Biosciences, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Cogent Biosciences, Inc. Stock Undervalued?The current Cogent Biosciences, Inc. [COGT] share price is $35.35. The Score for COGT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
COGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cogent Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cogent Biosciences, Inc. has on average historically risen by 77.9% based on the past 7 years of stock performance.
Cogent Biosciences, Inc. Stock Rating
Sell
46
Cogent Biosciences, Inc. (COGT)
is a Sell
Is Cogent Biosciences, Inc. overpriced?
-
Cogent Biosciences, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Cogent Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cogentbio.com
52-Week Data
52-Week High:
43.73
52-Week Low:
3.72
Prediction Charts
Market Cap:
5.4B
Price in USD:
35.35
Volume:
2.2M
Beta:
1.73
Technical Analysis
SMA50:
33.55
SMA100:
23.67
SMA200:
15.55
52-Wk Change:
335.88%
Stock Predictions
-
Is Cogent Biosciences, Inc. stock public?Yes, Cogent Biosciences, Inc. is a publicly traded company.
-
What is the Cogent Biosciences, Inc. stock quote today?The Cogent Biosciences, Inc. stock price is 35.35 USD today.
-
How to buy Cogent Biosciences, Inc. stock online?You can buy Cogent Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 39.49 | 37.90 | 40.04 | 37.23 |
| Dec-19 | 38.58 | 39.55 | 39.94 | 38.00 |
| Dec-22 | 39.00 | 39.34 | 39.94 | 38.31 |
| Dec-23 | 39.05 | 40.17 | 40.59 | 38.60 |
| Dec-24 | 39.90 | 39.73 | 40.40 | 39.60 |
| Dec-26 | 39.43 | 38.88 | 39.47 | 38.42 |
| Dec-29 | 38.60 | 37.92 | 38.82 | 37.80 |
| Dec-30 | 37.92 | 37.12 | 38.63 | 36.54 |
| Dec-31 | 35.75 | 35.52 | 36.48 | 34.18 |
| Jan-5 | 34.59 | 34.26 | 34.74 | 32.93 |
| Jan-6 | 34.46 | 34.78 | 35.08 | 33.75 |
| Jan-7 | 35.22 | 36.27 | 37.01 | 34.50 |
| Jan-8 | 35.72 | 35.57 | 36.06 | 34.61 |
| Jan-9 | 36.00 | 35.35 | 36.88 | 35.28 |
Cogent Biosciences, Inc. Earnings
Cogent Biosciences, Inc. Earnings Report: Per Share Cogent Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cogent Biosciences, Inc. Forecast Revenue Growth
Cogent Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Cogent Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $1.37 per share.
* Cogent Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.